Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

07-1398 Anti-phospho-Akt (Thr308) Antibody

This Anti-phospho-Akt (Thr308) Antibody is validated for use in IH(P) for the detection of phospho-Akt (Thr308).

Anti-phospho-Akt (Thr308) Antibody MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Signaling Research Sub-Category: PI3K, Akt, & mTOR Signaling Gene Symbol: AKT , C-AKT, EC 2.7.11.1, MGC99656, PKB , PKB-ALPHA , RAC, RAC-ALPHA , RAC-PK-alpha UniProt Number: P31749
07-1398
100 µL  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Special Offers

100% Performance Guaranteed

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
H, M, R, B, Xn, CaIH(P)RbAffinity PurifiedPolyclonal Antibody
Description
Catalogue Number07-1398
DescriptionAnti-phospho-Akt (Thr308) Antibody
Alternate Names
  • Protein kinase B
  • RAC-alpha serine/threonine-protein kinase
  • murine thymoma viral (v-akt) oncogene homolog-1
  • rac protein kinase alpha
  • v-akt murine thymoma viral oncogene homolog 1
Background InformationAkt/PKB is a Ser/Thr kinase and a major known effecter of the PI3 Kinase pathway. It is involved in multiple signaling pathways that relate to many biological processes including metabolism, apoptosis, cell cycle control, angiogenesis, differentiation, and cell growth and proliferation. In mammals, three isoforms of Akt (Akt1/PKCα, Akt2/PKBβ, and Akt3/PKBγ) exists. They exhibit a high degree of homology, but differ slightly in the localization of their regulatory phosphorylation sites. Akt1 is the predominant isoform that is in most tissues and is thought to have a dominant role in growth, survival, embryonic development, and adipocyte differentiation. Akt2 is correlated with the regulation of glucose homeostasis and is the predominant isoform expressed in insulin-responsive tissues. Akt3 is abundant in brain tissue. Each Akt isoform is composed of three functionally distinct regions: an N-terminal Pleckstrin Homology (PH) domain that provides a lipid-binding module, a central catalytic domain containing Thr308, and a C-terminal hydrophobic motif containing Ser473. The activation of AKT is dependent on a dual regulatory mechanism that requires both its translocation to the plasma membrane and dual phosphorylation on Thr308 and Ser473 by PDK1 and the TORC2 complex, respectively.
References
Product Information
FormatAffinity Purified
PresentationAntigen affinity purified rabbit serum in 0.1M Tris-Glycine (pH7.4), 150mM NaCl, with 0.05% NaN3.
Quality LevelMQ100
Applications
ApplicationThis Anti-phospho-Akt (Thr308) Antibody is validated for use in IH(P) for the detection of phospho-Akt (Thr308).
Key Applications
  • Immunohistochemistry (Paraffin)
Applications Not Recommended
  • Western Blotting
Application NotesImmunohistochemistry only

Western Blot Analysis:
Not recommended for WB as it gives multiple bands. Please refer to 05-802R
Biological Information
ImmunogenKLH-conjugated synthetic peptide containing the Thr308 sequence and surrounding amino acids of human, mouse, rat, bovine and chicken Akt1. Human and mouse Akt2 shares 11/12 amino acids and rat Akt3 shares 10/12 amino acids with the peptide immunogen sequence.
EpitopeThr308 (Catalytic Domain)
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostRabbit
SpecificityDetects Akt only when phosphorylated on Thr308.
IsotypeIgG
Species Reactivity
  • Human
  • Mouse
  • Rat
  • Bovine
  • Xenopus
  • Canine
Species Reactivity NoteMouse tested. Expected to react with Human, Rat, Chicken, Dog, Xenopus, and Cow based on 100% immunogen sequence homology.
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThe serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq].

Transcript Variant: This variant (3) lacks the 5' exon, but has a upstream alternate 5' exon, as compared to variant 1. Variants 1 and 3 encode the same protein.
Gene Symbol
  • AKT
  • C-AKT
  • EC 2.7.11.1
  • MGC99656
  • PKB
  • PKB-ALPHA
  • RAC
  • RAC-ALPHA
  • RAC-PK-alpha
Modifications
  • Phosphorylation
Purification MethodAntigen affinity purified against both the phosphorylated and the non-phosphorylated peptides of Akt (Thr308).
UniProt Number
UniProt SummaryFUNCTION: General protein kinase capable of phosphorylating several known proteins. Phosphorylates TBC1D4. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). Plays a role in glucose transport by mediating insulin-induced translocation of the GLUT4 glucose transporter to the cell surface. Mediates the antiapoptotic effects of IGF-I. Mediates insulin-stimulated protein synthesis, partly by playing a role in both insulin-induced phosphorylation of 4E-BP1 and in insulin-induced activation of p70 S6 kinase. Promotes glycogen synthesis by mediating the insulin-induced activation of glycogen synthase. Ref.4 Ref.8 Ref.12 Ref.13 Ref.16 Ref.20

Catalytic activity ATP + a protein = ADP + a phosphoprotein. Ref.4 Ref.20 Ref.1

ENZYME REGULATION:Three specific sites, one in the kinase domain (Thr-308) and the two other ones in the C-terminal regulatory region (Ser-473 and Tyr-474), need to be phosphorylated for its full activation. Ref.8 Ref.6

SUBUNIT STRUCTURE: Interacts with AGAP2 isoform 2 (PIKE-A) in the presence of guanine nucleotides. The C-terminus interacts with CCDC88A/GRDN and THEM4. Interacts with AKTIP. Interacts (via PH domain) with MTCP1, TCL1A AND TCL1B. Interacts with CDKN1B; the interaction phosphorylates CDKN1B promoting 14-3-3 binding and cell-cycle progression. Ref.13 Ref.16 Ref.20 Ref.9 Ref.10 Ref.11 Ref.15 Ref.17 Ref.18 Ref.19

SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell membrane. Note= Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Ref.11

TISSUE SPECIFICITY: In all human cell types so far analyzed. Ref.4

DOMAIN: Binding of the PH domain to the phosphatidylinositol 3-kinase alpha (PI(3)K) results in its targeting to the plasma membrane.

The AGC-kinase C-terminal mediates interaction with THEM4.

PTM: Phosphorylation on Thr-308, Ser-473 and Tyr-474 is required for full activity. Ser-473 phosphorylation by the Rictor-mTor complex favors Thr-308 phosphorylation by PDPK1. Ser-473 phosphorylation is enhanced by interaction with AGAP2 isoform 2 (PIKE-A). Ser-473 phosphorylation is enhanced in focal cortical dysplasias with Taylor-type balloon cells.

SIMILARITY:Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. RAC subfamily.

Contains 1 AGC-kinase C-terminal domain.

Contains 1 PH domain.

Contains 1 protein kinase domain.
Molecular Weight60 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceImmunohistochemistry Analysis:
Antibody diluted to 1:500, IHC-Select Detection with HRP-DAB.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution.
Packaging Information
Material Size100 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
07-1398 04053252408441

Documentation

Anti-phospho-Akt (Thr308) Antibody SDS

Title

Safety Data Sheet (SDS) 

Anti-phospho-Akt (Thr308) Antibody Certificates of Analysis

TitleLot Number
Anti-phospho-Akt (Thr308) (IHC only) - 2147123 2147123
Anti-phospho-Akt (Thr308) (IHC only) - 2433378 2433378
Anti-phospho-Akt (Thr308) (IHC only) - 2073644 2073644
Anti-phospho-Akt (Thr308) (IHC only) - 2298423 2298423
Anti-phospho-Akt (Thr308) (IHC only) - 3245130 3245130
Anti-phospho-Akt (Thr308) (IHC only) - 3398055 3398055
Anti-phospho-Akt (Thr308) (IHC only) - 3980747 3980747
Anti-phospho-Akt (Thr308) (IHC only) - 4095346 4095346
Anti-phospho-Akt (Thr308) (IHC only) - NG1593355 NG1593355
Anti-phospho-Akt (Thr308) (IHC only) - NG1667752 NG1667752
Show more